Literature DB >> 21178496

Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.

Magdia De Jesus1, André Moraes Nicola, Siu-Kei Chow, Ian R Lee, Shuhua Nong, Charles A Specht, Stuart M Levitz, Arturo Casadevall.   

Abstract

The capsular polysaccharides of Cryptococcus neoformans have historically been divided into three components namely, glucuronoxylomannan (GXM), galactoxylomannan (GalXM), and mannoprotein (MP) but their relative spatial-geographical relationship in the capsule is unknown.  To explore this problem would require the capacity for visualizing these components in the capsule.  Prior studies have reported serological reagents to GXM and GalXM but no antibodies are available against MPs.  Consequently, we immunized Balb/c mice with C. neoformans recombinant mannoprotein 98 and recovered twelve monoclonal antibodies (mAbs) of which one, an IgG2a designated 18F2, bound to intact cells by immunofluorescence. mAb 18F2 bound to the cell wall surface in acapsular and encapsulated cells.  Using mAb 18F2 and previously generated antibodies to GXM and GalXM we have established the localization of three capsular components GXM, GalXM and one type of mannoprotein, MP98 on the C. neoformans cell.  The results show that MP98, like GalXM, is found near the cell wall and this information allows us to begin to discern the geography of the cryptococcal capsule.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178496      PMCID: PMC3073359          DOI: 10.4161/viru.1.6.13451

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  38 in total

1.  Localization of mannoprotein in Cryptococcus neoformans.

Authors:  S E Vartivarian; G H Reyes; E S Jacobson; P G James; R Cherniak; V R Mumaw; M J Tingler
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

2.  Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans.

Authors:  Richard A Eigenheer; Young Jin Lee; Eduardo Blumwald; Brett S Phinney; Angie Gelli
Journal:  FEMS Yeast Res       Date:  2007-01-19       Impact factor: 2.796

3.  Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo.

Authors:  Lauren E Yauch; Michael K Mansour; Stuart M Levitz
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors.

Authors:  Michael K Mansour; Larry S Schlesinger; Stuart M Levitz
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Authors:  A Casadevall; J Mukherjee; S J Devi; R Schneerson; J B Robbins; M D Scharff
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

6.  Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.

Authors:  S H Turner; R Cherniak; E Reiss
Journal:  Carbohydr Res       Date:  1984-02-15       Impact factor: 2.104

7.  The Cryptococcus neoformans STE12alpha gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific.

Authors:  B L Wickes; U Edman; J C Edman
Journal:  Mol Microbiol       Date:  1997-12       Impact factor: 3.501

8.  Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.

Authors:  Magdia De Jesus; André Moraes Nicola; Marcio L Rodrigues; Guilhem Janbon; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2008-10-24

9.  The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid.

Authors:  Christian Heiss; J Stacey Klutts; Zhirui Wang; Tamara L Doering; Parastoo Azadi
Journal:  Carbohydr Res       Date:  2009-03-10       Impact factor: 2.104

10.  Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.

Authors:  Magdia De Jesus; Siu-Kei Chow; Radames J B Cordero; Susana Frases; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2010-01-08
View more
  15 in total

1.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

Review 2.  Virulence-Associated Enzymes of Cryptococcus neoformans.

Authors:  Fausto Almeida; Julie M Wolf; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2015-10-09

3.  Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties.

Authors:  Caroline L Ramos; Fernanda L Fonseca; Jessica Rodrigues; Allan J Guimarães; Leonardo P Cinelli; Kildare Miranda; Leonardo Nimrichter; Arturo Casadevall; Luiz R Travassos; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2012-05-04

4.  In good company: association between fungal glycans generates molecular complexes with unique functions.

Authors:  Marcio L Rodrigues; Leonardo Nimrichter
Journal:  Front Microbiol       Date:  2012-07-09       Impact factor: 5.640

5.  Cryptococcus neoformans modulates extracellular killing by neutrophils.

Authors:  Asfia Qureshi; Angus Grey; Kristie L Rose; Kevin L Schey; Maurizio Del Poeta
Journal:  Front Microbiol       Date:  2011-09-21       Impact factor: 5.640

6.  Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformans.

Authors:  Oscar Zaragoza
Journal:  Front Microbiol       Date:  2011-09-06       Impact factor: 5.640

7.  Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.

Authors:  Charles A Specht; Chrono K Lee; Haibin Huang; Donald J Tipper; Zu T Shen; Jennifer K Lodge; John Leszyk; Gary R Ostroff; Stuart M Levitz
Journal:  MBio       Date:  2015-12-22       Impact factor: 7.867

8.  The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients.

Authors:  Eva Pericolini; Alessia Alunno; Elena Gabrielli; Elena Bartoloni; Elio Cenci; Siu-Kei Chow; Giovanni Bistoni; Arturo Casadevall; Roberto Gerli; Anna Vecchiarelli
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

9.  Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells.

Authors:  Pedro A C Teixeira; Luciana L Penha; Lucia Mendonça-Previato; Jose O Previato
Journal:  Front Cell Infect Microbiol       Date:  2014-08-19       Impact factor: 5.293

Review 10.  Immune Recognition of Fungal Polysaccharides.

Authors:  Brendan D Snarr; Salman T Qureshi; Donald C Sheppard
Journal:  J Fungi (Basel)       Date:  2017-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.